1Biessels, GJ, Kappelle, AC, Bravenboer, B, et al. (1994) Cerebral function in diabetes mellitus. Diabetologia 37, 643–650.
2McCarty, MF (1997) Exploiting complementary therapeutic strategies for the treatment of type II diabetes and prevention of its complications. Med Hypotheses 49, 143–152.
3Zimmet, PZ (1995) The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography. Diabetes Care 18, 1050–1064.
4Ames, BN, Shigenaga, MK & Hagen, TM (1995) Mitochondrial decay in aging. Biochim Biophys Acta 1271, 165–170.
5Lowell, BB & Shulman, GI (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307, 384–387.
6Cai, X, Jia, H, Liu, Z, et al. (2008) Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+)-induced cellular model of Parkinson's disease. J Neurosci Res 86, 3622–3634.
7Liu, J, Shen, W, Zhao, B, et al. (2009) Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: hope from natural mitochondrial nutrients. Adv Drug Deliv Rev 61, 1343–1352.
8Fuchs, J, Packer, L & Zimmer, G (1997) Lipoic Acid in Health and Disease. New York: Marcel Dekker, Inc.
9Liu, J (2008) The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview. Neurochem Res 33, 194–203.
10Janssen, U, Vassiliadou, A, Riley, SG, et al. (2004) The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat. J Nephrol 17, 769–773.
11Portha, B, Lacraz, G, Kergoat, M, et al. (2009) The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes? Mol Cell Endocrinol 297, 73–85.
12Palmeira, CM, Ferreira, FM, Santos, DL, et al. (1999) Higher efficiency of the liver phosphorylative system in diabetic Goto–Kakizaki (GK) rats. FEBS Lett 458, 103–106.
13Duhault, J & Koenig-Berard, E (1997) Diabetes mellitus and its animal models. Therapie 52, 375–384.
14Shen, W, Hao, J, Tian, C, et al. (2008) A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto–Kakizaki rats. PLoS One 3, e2328.
15Hao, J, Shen, W, Tian, C, et al. (2009) Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto–Kakizaki rats. J Cell Mol Med 13, 701–711.
16Gastaldelli, A, Baldi, S, Pettiti, M, et al. (2000) Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49, 1367–1373.
17Clore, JN, Post, EP, Bailey, DJ, et al. (1992) Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast. J Clin Endocrinol Metab 74, 660–666.
18Lonardo, A, Lombardini, S, Ricchi, M, et al. (2005) Review Article: hepatic steatosis and insulin resistance. Aliment Pharmacol Ther 22, Suppl. 2, 64–70.
19Almon, RR, DuBois, DC, Lai, W, et al. (2009) Gene expression analysis of hepatic roles in cause and development of diabetes in Goto–Kakizaki rats. J Endocrinol 200, 331–346.
21Krahenbuhl, S, Chang, M, Brass, EP, et al. (1991) Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria. J Biol Chem 266, 20998–21003.
22Long, J, Wang, X, Gao, H, et al. (2007) d-Galactose toxicity in mice is associated with mitochondrial dysfunction: protecting effects of mitochondrial nutrient R-alpha-lipoic acid. Biogerontology 8, 373–381.
23Long, J, Gao, H, Sun, L, et al. (2009) Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson's disease model. Rejuvenation Res 12, 321–331.
24Sun, L, Luo, C, Long, J, et al. (2006) Acrolein is a mitochondrial toxin: effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Mitochondrion 6, 136–142.
25Li, X, Liu, Z, Luo, C, et al. (2008) Lipoamide protects retinal pigment epithelial cells from oxidative stress and mitochondrial dysfunction. Free Radic Biol Med 44, 1465–1474.
26Jia, L, Liu, Z, Sun, L, et al. (2007) Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid. Invest Ophthalmol Vis Sci 48, 339–348.
27Pabst, MJ, Habig, WH & Jakoby, WB (1974) Glutathione S-transferase A. A novel kinetic mechanism in which the major reaction pathway depends on substrate concentration. J Biol Chem 249, 7140–7147.
28Levine, RL, Garland, D, Oliver, CN, et al. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186, 464–478.
29Shen, W, Liu, K, Tian, C, et al. (2008) R-alpha-lipoic acid and acetyl-l-carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes. Diabetologia 51, 165–174.
30Ferreira, FM, Palmeira, CM, Matos, MJ, et al. (1999) Decreased susceptibility to lipid peroxidation of Goto–Kakizaki rats: relationship to mitochondrial antioxidant capacity. Life Sci 65, 1013–1025.
31Ferreira, FM, Palmeira, CM, Seica, R, et al. (2003) Diabetes and mitochondrial bioenergetics: alterations with age. J Biochem Mol Toxicol 17, 214–222.
32Ferreira, FM, Palmeira, CM, Seica, R, et al. (1999) Alterations of liver mitochondrial bioenergetics in diabetic Goto–Kakizaki rats. Metabolism 48, 1115–1119.
33Ferreira, FM, Seica, R, Oliveira, PJ, et al. (2003) Diabetes induces metabolic adaptations in rat liver mitochondria: role of coenzyme Q and cardiolipin contents. Biochim Biophys Acta 1639, 113–120.
34Carreras, MC, Franco, MC, Peralta, JG, et al. (2004) Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease. Mol Aspects Med 25, 125–139.
35Tarze, A, Deniaud, A, Le Bras, M, et al. (2007) GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 26, 2606–2620.
36Bogacka, I, Xie, H, Bray, GA, et al. (2005) Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54, 1392–1399.
37Reddy, JK & Rao, MS (2006) Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290, G852–G858.
38Hashimoto, T, Cook, WS, Qi, C, et al. (2000) Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 275, 28918–28928.